A detailed history of Moseley Investment Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Moseley Investment Management Inc holds 3,671 shares of LLY stock, worth $3.22 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
3,671
Previous 3,890 5.63%
Holding current value
$3.22 Million
Previous $3.03 Million 9.81%
% of portfolio
1.56%
Previous 1.52%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$724.87 - $909.04 $158,746 - $199,079
-219 Reduced 5.63%
3,671 $3.32 Million
Q1 2024

Apr 04, 2024

BUY
$592.2 - $792.28 $8,290 - $11,091
14 Added 0.36%
3,890 $3.03 Million
Q4 2023

Jan 25, 2024

BUY
$525.19 - $619.13 $272,573 - $321,328
519 Added 15.46%
3,876 $2.26 Million
Q3 2023

Oct 16, 2023

SELL
$434.7 - $599.3 $15,214 - $20,975
-35 Reduced 1.03%
3,357 $1.8 Million
Q2 2023

Jul 06, 2023

BUY
$350.74 - $468.98 $225,876 - $302,023
644 Added 23.44%
3,392 $1.59 Million
Q1 2023

May 03, 2023

BUY
$310.63 - $364.82 $2,174 - $2,553
7 Added 0.26%
2,748 $943,000
Q4 2022

Jan 24, 2023

SELL
$321.55 - $374.67 $1,607 - $1,873
-5 Reduced 0.18%
2,741 $0
Q3 2022

Oct 13, 2022

BUY
$296.48 - $337.87 $13,341 - $15,204
45 Added 1.67%
2,746 $888,000
Q2 2022

Jul 15, 2022

BUY
$278.73 - $327.27 $151,907 - $178,362
545 Added 25.28%
2,701 $876,000
Q1 2022

Apr 21, 2022

BUY
$234.69 - $291.66 $23,469 - $29,166
100 Added 4.86%
2,156 $617,000
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $81,247 - $105,093
450 Added 28.02%
2,056 $472,000
Q4 2020

Jan 26, 2021

BUY
$130.46 - $172.63 $652 - $863
5 Added 0.31%
1,606 $271,000
Q4 2019

Jan 15, 2020

BUY
$106.92 - $132.43 $171,178 - $212,020
1,601 New
1,601 $210,000
Q3 2019

Oct 30, 2019

SELL
$106.79 - $116.16 $257,577 - $280,177
-2,412 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$111.31 - $131.02 $268,479 - $316,020
2,412 New
2,412 $313,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $835B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Moseley Investment Management Inc Portfolio

Follow Moseley Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moseley Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Moseley Investment Management Inc with notifications on news.